Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 579 for sleep

Edit search filters
  1. Mesenchymal Stem Cell Therapy for Lung Rejection

  2. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM

    Rochester, MN

  3. A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  4. A Study Comparing Sublobar Resection versus Stereotactic Ablative Radiotherapy for Lung Cancer

  5. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

    Rochester, MN

  6. Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

    Jacksonville, FL, Rochester, MN

  8. A Study to Evaluate Firstline Pembrolizumab Alone or in Combination with Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients with Stage IV Non-squamous Non-small Cell Lung Cancer

    La Crosse, WI, Albert Lea, MN, Eau Claire, WI, Mankato, MN, Jacksonville, FL, Rochester, MN

  9. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab

    Rochester, MN

  10. Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer